Bookmark and Share

About Us

The Division of Endocrinology, Diabetes and Nutrition has enjoyed unprecedented growth to become one of the largest and successful Divisions’ of Endocrinology in the country. Guided by its mission of excellence in research and discovery, clinical care, and education, we have made great strides in each of these arenas. The faculty are extraordinarily collegial and collaborative and have diverse interests spanning clinical endocrinology/diabetes, clinical research/trials, epidemiology, cellular and molecular biology, functional genomics, and molecular and statistical genetics.

Future challenges include continued growth of the research program, ongoing improvement of current clinical programs, and the development of new programs (inpatient diabetes management and diabetes prevention) to meet the current and future needs of patients with endocrine disorders and diabetes.

Facilities & Resources

All of the Division’s faculty members have private offices distributed in the research area, clinic sites, or Baltimore VA Medical Center. Research resources include approximately 7,000 square feet of state-of-the-art wet lab space fully equipped to perform molecular, cellular, functional genomics and high-throughput genetics research (Howard Hall 4 and 5); over 1,500 square feet of office space with networked Unix and PC computer hardware for the Genetic Epidemiology Unit led by Dr. Braxton Mitchell (MSTF 3); and approximately 100 square feet of clinical research space at the University of Maryland Center for Diabetes and Endocrinology (UMMC Midtown). The Division’s Clinical Research Unit is equipped to perform investigator-initiated clinical research and therapeutic trials for diabetes, diabetic complications, obesity and other endocrine disorders. The UMCDE Metabolic and Pharmacogenetics Clinical Research Unit is adjacent to the clinic and consists of 100 sq ft of space fully equipped with the requisite equipment and supplies for medical screening evaluation, anthropometry, and metabolic studies including oral glucose tolerance tests (OGTT), and pharmacological interventions.

The Nutrition Obesity Research Center (NORC) of Maryland is a center funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in 2005. The mission of the NORC of Maryland is to foster multidisciplinary research approaches to understanding the impact of nutrition on risk for chronic disease and translate this knowledge into effective clinical treatments and prevention efforts.

Investigators from University of Maryland and the Johns Hopkins University have also joined together to create the Baltimore Diabetes Research and Training Center (DRTC). The Center fosters collaborative, multidisciplinary diabetes and endocrinology research, and translates that research into programs to train health care professionals in the diagnosis and management of diabetes.

Core resources for the Nutrition Obesity Research Center (NORC) of Maryland and the Baltimore Diabetes Research and Training Center (DRTC) are housed in the EDN Division's research space. Resources from these NIH-funded Centers are accessible to its members at the University of Maryland, Johns Hopkins University, and the United States Department of Agriculture (USDA).

The Amish Research Clinic is located in Strasburg, PA. Staffed by 10 full-time employees, this 1,500 square foot clinical research facility performs field-work, recruitment, and phenotypic characterization of Amish research volunteers for more than 10 concurrent studies.

The Hypertension and Endocrine Research Unit (HEU), directed by Dr. Nanette Steinle, is a large clinical research facility at the Baltimore VAMC. This 1500 square foot facility is equipped with examination rooms, clinical lab, procedure rooms and data storage. Multiple clinical research studies have been performed in the fields of hypertension, dyslipidemia, and diabetes both single and multiple site, including the ALLHAT Study and ACCORD Study. Finally, several of the Division’s clinical investigators utilize the University of Maryland General Clinical Research Center for some of their more intensive NIH-funded protocols.